MaxCyte
MaxCyte, Inc., a leading player in the cell engineering industry, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 1998, the company has established itself as a pioneer in the development of cell-based therapies and drug discovery solutions. MaxCyte's core offerings include its proprietary Flow Electroporation® technology, which enables the efficient delivery of nucleic acids into various cell types. This unique approach not only enhances the development of cell therapies but also accelerates the discovery of new drugs. With a strong market position, MaxCyte has achieved notable milestones, including partnerships with major pharmaceutical companies and biotechs, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
DitchCarbon Score
How does MaxCyte's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MaxCyte's score of 20 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MaxCyte's reported carbon emissions
MaxCyte, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MaxCyte may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As of now, MaxCyte does not inherit emissions data from any parent or related organizations, indicating that their climate commitments and emissions reporting are independent. Without specific targets or achievements, it is unclear how the company plans to address its carbon footprint or contribute to broader climate initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments, which may set a precedent for MaxCyte to follow in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MaxCyte is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
